Literature DB >> 25258113

The molecular response of vanadium complexes of nicotinoyl hydrazone in cervical cancers--a possible interference with HPV oncogenic markers.

Rakesh S Nair1, Mini Kuriakose2, Veena Somasundaram1, Vinesh Shenoi3, M R Prathapachandra Kurup4, Priya Srinivas5.   

Abstract

AIMS: Hydrazones belonging to the class of NNO donor Schiff bases are reported to have extensive anti-viral activity and anti-neoplastic activity against certain cancers such as colon cancer, hepatocellular carcinoma and testicular cancer. Here we aim to study the possible effects of two novel nicotinoyl hydrazones on Human papillomavirus (HPV) infected cervical cancers. MAIN
METHODS: The effect of vanadium complexes on the proliferation of SiHa and HeLa cells was analyzed using MTT assay. The apoptotic potentials of the complexes were assessed by their ability to induce DNA condensation as well as loss of mitochondrial membrane potential. Caspase activity assay and DNA content analysis were performed to understand the mechanism of apoptotic induction. RT-PCR analysis of cell cycle genes, GADD45, p53, p21 and HPV specific oncogenes, E6 and E7 were used to elucidate the molecular mechanism of the complexes. KEY
FINDINGS: OVK 49 exhibits an increased apoptosis inducing potential when compared to OVK 89 in HPV16 positive SiHa cells compared to HPV18 positive HeLa. A down regulation for E6 and E7 mRNA transcripts along with the induction of p53 protein in SiHa cells were observed when treated with OVK 49 indicating that OVK 49 might have promising anti-cancer activity against HPV16 positive cervical cancers. SIGNIFICANCE: This is the first study demonstrating that vanadium complexes could induce a p53 dependent apoptotic mechanism in high risk HPV16-positive cervical cancers.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPV16-positive; Nicotinoyl hydrazones; Oxidovanadium; SiHa

Mesh:

Substances:

Year:  2014        PMID: 25258113     DOI: 10.1016/j.lfs.2014.09.011

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Selective Cytotoxicity of Complexes with N,N,N-Donor Dipodal Ligand in Tumor Cells.

Authors:  Malgorzata Tyszka-Czochara; Anna Adach; Tomasz Grabowski; Paweł Konieczny; Paweł Pasko; Joanna Ortyl; Tomasz Świergosz; Marcin Majka
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

2.  Crystal structure of 4-{(E)-[2-(pyridin-4-ylcarbon-yl)hydrazin-1-yl-idene]meth-yl}phenyl acetate monohydrate.

Authors:  Riya Datta; V Ramya; M Sithambaresan; M R Prathapachandra Kurup
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-03

3.  Crystal structure of aqua-[(E)-N'-(5-bromo-2-oxido-benzyl-idene-κO)benzohydrazidato-κ(2) O,N']dioxidomolybdenum(VI) di-methyl-formamide monosolvate.

Authors:  Radhika Sudheer; M Sithambaresan; N R Sajitha; E Manoj; M R Prathapachandra Kurup
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-05-28

Review 4.  Vanadium Compounds as PTP Inhibitors.

Authors:  Elsa Irving; Andrew W Stoker
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

5.  Crystal structure of N'-[(E)-3,5-di-chloro-2-hy-droxy-benzyl-idene]-4-nitro-benzo-hydrazide di-methyl-formamide monosolvate.

Authors:  Bibitha Joseph; N R Sajitha; M Sithambaresan; E B Seena; M R Prathapachandra Kurup
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-10-07

6.  Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.

Authors:  Hamid Bakhshi Aliabad; Soudeh Khanamani Falahati-Pour; Hadis Ahmadirad; Maryam Mohamadi; Mohammad Reza Hajizadeh; Mehdi Mahmoodi
Journal:  Biometals       Date:  2018-09-25       Impact factor: 2.949

Review 7.  Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells.

Authors:  Szymon Kowalski; Dariusz Wyrzykowski; Iwona Inkielewicz-Stępniak
Journal:  Molecules       Date:  2020-04-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.